MYB Program Helps Consumers Rein in Drug Costs
National health care spending
keeps climbing, but your patients with Humana health coverage are
learning new tactics to lower their out-of-pocket spending on prescription
drugs.
Humana’s Maximize Your Benefit (MYB) program, which has helped
consumers save big on pharmacy costs since its inception in early
2001, encourages Humana members taking certain popular, high-priced
prescription drugs to talk to their physicians about lower-cost
alternatives.
MYB focuses on drugs in Level Three of the Humana Drug List —
usually brand-name drugs that require higher copayments but often
have lower-costing and clinically appropriate alternatives in Level
One or Level Two.
“The purpose of the program is to help Humana members manage
their out-of-pocket prescription drug costs,” said Tracy Timberlake,
operations manager, pharmacy management for Humana. “One way
they can do this is to talk to their physicians about possible lower-cost
alternatives for the drug originally prescribed.”
Consumer information from the MYB program also can help Medicare
Advantage members manage their maximum allowable benefit.
Although Humana gives its members information about prescription
drugs, the placement of a pharmaceutical on the Humana Drug List
does not indicate its appropriateness or clinical effectiveness
for any member or any specific illness.
By keeping the focus on consumer education, the MYB program helps
counter the influence of direct-to-consumer drug advertising campaigns
that suggest patients ask their physicians about expensive brand-name
drugs.
Humana’s MYB program contacts members by telephone, mail or
secured e-mail after they fill prescriptions for certain drugs on
Level Three of the Humana Drug List. The program provides consumers
with the names of alternate prescription drugs that could treat
the condition or illness and encourages consumers to talk to the
prescribing physician about their prescribed drugs.
To review Humana’s Drug List, go to
www.humana.com,
and select
“Prescription Drug.”
Back to top
|